Islamic Finance Principles Assessment
Riba — Does Bitchemical Token involve interest?
Bitchemical's own whitepaper frames token rewards as a year-end, profit-linked dividend from a real chemical lab and AI business, not fixed interest. However, one unofficial 2022 source claims the token can be staked to "earn interest" through a synthetic cToken pegged to USDT — a claim the project's primary materials do not corroborate. Until this is officially clarified, Muslim investors should treat the interest claim as an unresolved risk rather than a confirmed feature.
Assessment: Riba Dominant
Score: 39/100
Our methodology examines 10 criteria to evaluate how well Bitchemical Token avoids interest-based mechanisms.
Bitchemical's stated revenue comes from an operating chemical laboratory/R&D business and token sales, with year-end profits distributed pro-rata to holders as a "dividend" — a structure closer to equity profit-sharing than a fixed-return instrument. This is a relatively favorable framing compared to explicit interest income. However, treasury composition is undisclosed in available sources, so it cannot be confirmed whether any idle funds are held in interest-bearing instruments. The absence of disclosure here is a transparency gap rather than confirmed riba, but it prevents a clean assessment of the treasury's compliance.
The only explicit "earn interest" language found comes from a 2022 third-party LinkedIn post describing a "Bit Treasury" mechanism using a synthetic cToken tracking USDT — a structure that, if real and current, would resemble Qard-with-increment and raise a genuine riba concern. This contradicts the whitepaper's "no hidden code" framing and is not confirmed by any primary project documentation. The official reward described elsewhere is the profit-linked, variable year-end dividend tied to business performance, which is structurally more permissible, but the contradiction between sources leaves the actual reward mechanism unresolved.
Gharar — How much uncertainty does Bitchemical Token involve?
Bitchemical carries considerable uncertainty: no credentialed named founders, inconsistent tickers and contract addresses across listing sites, and near-zero market cap and liquidity on multiple exchanges. An open-source codebase and a completed CertiK audit provide some mitigation, but core details — treasury composition, staking mechanics, vesting — remain undisclosed. On balance, this is a project with meaningful, unresolved gharar.
Assessment: Excessive Gharar (High Uncertainty)
Score: 30.7/100
Our methodology examines 15 criteria including team transparency, audit quality, and governance.
No individually named, credentialed founders are confirmed; the closest description is a generic reference to "chemical engineers, chemists, and IT professionals," and one LinkedIn profile cannot be reliably linked to the project. The smart contract code is open-source on GitHub, which is a positive transparency signal. Yet multiple listing pages show conflicting tickers (BCHEC vs BCHEM) and different contract addresses for what is presented as the same token, and treasury composition and any team/investor vesting schedule are undisclosed — all of which weaken confidence in the project's overall disclosure quality.
A CertiK audit dated 13 June 2025 covers the Bitchemical LAB&AI contract, reporting three findings — two resolved, one acknowledged, none declined — and no other named audit firm appears in available sources. This is a genuine mitigating factor. However, the audit does not address staking mechanics, dividend distribution logic, or treasury holdings, all of which remain undocumented. Given the contradictory and unofficial nature of the only staking references found, and the unresolved ticker/contract discrepancies, significant operational and disclosure gaps persist even after the audit.
Maysir — Does Bitchemical Token involve gambling or speculation?
Bitchemical is tied to a described real-world chemical R&D and AI business rather than being a purely speculative vehicle, which distinguishes it from pure gambling instruments. That said, the project's own presale marketing explicitly promised early buyers profit at listing, and promotional materials elsewhere encourage "arbitrage trading" of the token — speculative framing that originates from the project's own promotion, not merely third-party misuse. This is a genuine maysir consideration investors should weigh.
Assessment: Maysir / Qimar (Gambling)
Score: 30/100
Our methodology examines 11 criteria to determine whether Bitchemical Token is a gambling instrument or a genuine economic tool.
Bitchemical's stated utility centers on a governance and growth token for a business combining chemical laboratory R&D, AI workflows, and blockchain data management. If the underlying lab and R&D operations are genuine and revenue-generating, as claimed, the token's dividend mechanism reflects participation in productive economic activity rather than a zero-sum wager — a meaningful distinction from pure speculation, provided the business substance is verifiable and ongoing.
Against this claimed utility sits evidence of heavy speculative framing: presale copy explicitly promoted profiting from a low entry price ahead of listing, and other promotional content encourages arbitrage trading of the token. Market data further shows near-zero circulating supply, $0.00 market cap on some exchanges, and daily volumes as low as $10 — patterns consistent with thin, possibly abandoned trading rather than active productive use. This combination of self-promoted speculation and weak market substance tempers confidence that the token functions primarily as a utility instrument in practice.
The Full 27-Point Screening
1. Legitimacy (4 criteria)
| Criterion | Score | Analysis |
|---|
| Team Transparency | 20/100 | Only a vague, unnamed description of "chemical engineers, chemists and IT professionals" is available; no individually credentialed founders are traceable. |
| Fraud & Scam Risk | 25/100 | Sources directly show ticker/contract-address inconsistencies, near-zero market cap and liquidity, and profit-skewed presale marketing, all of which are rug-pull/scam-adjacent red flags. |
| Use Case Legitimacy | 30/100 | A real-world chemical/AI use case is claimed across multiple listing pages, but no evidence of actual usage, active users, or working product was found. |
| Ethical Practices | 65/100 | The chemical industry itself is not inherently prohibited, but the specific product lines are undisclosed (catalog "available on request"), so the coin's own design cannot be fully verified as haram-free. |
Summary: The team is unnamed and unverifiable, and market data reveals ticker/contract inconsistencies and near-zero trading activity that raise legitimacy concerns despite no confirmed regulatory action.
2. Project Operations (9 criteria)
| Criterion | Score | Analysis |
|---|
| Core Protocol Business | 65/100 | The base protocol is framed as supporting a chemical R&D and AI data business, a sector not inherently prohibited, though details are sparse. |
| Transaction Fees | 50/100 | The whitepaper claims no transaction tax and a company-funded annual burn, but a separate contested source claims an interest-bearing mechanism, leaving fee handling unclear. |
| Treasury Assets | 35/100 (low evidence) | No source discloses treasury composition or whether any holdings are interest-bearing. |
| Revenue Model | 45/100 | Revenue is described as coming from real lab services and token sales with profit "dividends" to holders, which is not clearly interest-based but is also not a clean utility-fee model. |
| Transparency | 45/100 | A whitepaper, open-source contract, and audit report all exist and are directly cited, but they contain contradictions (ticker/contract mismatches) that undercut confidence. |
| Governance | 25/100 | The token is called a "governance" token but voting mechanics are undocumented, and the audit notes the initial owner held 100% of supply, indicating centralization. |
| Launch Fairness | 20/100 | The whitepaper itself states the presale was priced low specifically so early buyers would profit once the listing price rose, a direct fairness concern. |
| Token Distribution | 30/100 (low evidence) | No breakdown of team, investor, or community token allocation or vesting is disclosed in any source. |
| Speculation/Utility Ratio | 15/100 | Exchange-facing marketing explicitly promotes "arbitrage trading" and profiting from price swings as a primary use, and real usage/liquidity data show a largely speculative, non-utility market. |
Summary: The token is positioned as a utility/governance instrument for a real chemical-tech and AI business with an open-source contract, but governance mechanics, treasury composition, and token allocation/vesting are largely undisclosed and launch fairness is questionable.
3. Financial Health (4 criteria)
| Criterion | Score | Analysis |
|---|
| Protocol Revenue | 55/100 | Sources describe revenue from a real chemical business rather than interest, but this is not independently verified and one contested source suggests an interest component. |
| Financial Status | 15/100 | Multiple listing pages directly show $0.00 market cap, 0 circulating supply reported, and minimal trading volume, indicating an unstable and largely inactive market. |
| Interest Assessment | 35/100 | One unofficial source claims staking "earns interest" via a synthetic cToken, contradicted by the whitepaper's "no secret code" language, leaving the interest question unresolved. |
| Audit Quality | 65/100 | A CertiK audit dated June 2025 is directly cited, finding three issues with two resolved and one acknowledged, none declined. |
Summary: The token's market standing is extremely weak and inconsistent across sources, only one audit (CertiK) was found, and no reliable evidence supports a native interest/lending feature at the base protocol beyond one contested third-party claim.
4. Token Economics (5 criteria)
| Criterion | Score | Analysis |
|---|
| Token Purpose | 40/100 | The token is marketed as a utility/governance token for a real business, but promotional material elsewhere emphasizes speculative trading over utility use. |
| Governance Rights | 35/100 | Governance rights are asserted in marketing language but no voting mechanism, proposal process, or holder rights are documented. |
| Rewards Distribution | 45/100 | Rewards are described as a year-end, profit-linked dividend tied to token balance, which is variable rather than fixed, but the equity-like framing is unusual for a utility token and undocumented in detail. |
| Speculation Controls | 15/100 | No lock-ups, vesting, or anti-whale mechanisms are disclosed, and marketing directly promotes speculative trading behavior. |
| Asset Backing | 30/100 | Value is said to derive from an underlying chemical/AI business, but no disclosed reserve, treasury, or verifiable asset backing supports this claim. |
Summary: The token blends a claimed real-world utility role with marketing that explicitly promotes price speculation, lacking disclosed anti-speculation controls or verifiable asset backing.
5. Staking Mechanism (5 criteria)
| Criterion | Score | Analysis |
|---|
| Mechanism Type | 20/100 | Staking is mentioned in only two inconsistent secondary sources with no clarity on custodial status, delegation model, or lock-up terms. |
| Islamic Contract Classification | 15/100 | One source explicitly describes staking as earning "interest," which suggests a Qard-with-increment structure, but this claim is unverified and contradicts the whitepaper's framing, leaving the classification unresolved. |
| Rewards Structure | 15/100 | The only reward description found uses "interest" language rather than a documented variable, activity-based reward source. |
| Documentation | 15/100 (low evidence) | No dedicated staking documentation, terms, or risk disclosures were found in these sources. |
| Shariah Alignment | 15/100 | The core question of whether any staking mechanism involves interest is directly contested and unresolved across the available sources. |
Summary: Staking is referenced only in thin, inconsistent secondary sources, including one unverified claim of interest-bearing rewards, leaving its existence, mechanics, and Shariah classification unresolved.
Overall Assessment: BCHEM presents as a niche chemical/AI-themed token with real-business aspirations but is hampered by transparency gaps, contested interest-related claims, and speculation-oriented marketing that leave several Shariah-relevant questions unanswered.
Written by ThanvirFounder, Ex Director S&P Global Energy
Reviewed by Imam Omar SiddiqiShariah Scholar